Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is myoepithelial carcinoma of soft tissue?
Myoepithelial carcinoma of soft tissue is a rare cancer that develops from myoepithelial cells — specialized cells that normally sit around glands and help squeeze out their secretions. In soft tissue it usually appears as a deep mass in the limbs, limb girdles, or trunk, and it can occur in both adults and children. It belongs to a family that ranges from benign myoepithelioma to malignant myoepithelial carcinoma, and pathologists tell them apart by how abnormal the cells look. Many of these tumors carry a rearrangement of a gene called EWSR1. Behavior varies: some are relatively indolent while others recur or spread to lymph nodes, lungs, or bone, so treatment is individualized around complete surgical removal, frequently combined with radiation, and long-term follow-up.
The main types
Doctors group myoepithelial carcinoma of soft tissue by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Soft-tissue myoepithelial carcinoma | The malignant form arising in the deep soft tissues of the limbs or trunk, with cells abnormal enough to behave as a cancer; often carries an EWSR1 gene rearrangement. |
| Myoepithelioma / mixed tumor (benign relative) | A benign or borderline cousin made of the same cell type; it is cured by removal but is distinguished from the carcinoma by its milder microscopic features. |
Staging, in plain terms
Myoepithelial carcinoma of soft tissue is staged like other soft-tissue sarcomas, based on the tumor's size and depth (T), spread to lymph nodes (N) or distant organs (M), and its grade under the microscope. Grade — how aggressive the cells look — and whether the tumor can be removed completely are the biggest factors in planning treatment. Childhood cases can behave differently and are managed at pediatric sarcoma centers.
| Soft-tissue sarcoma TNM + grade | What it generally means |
|---|---|
| Localized, low-grade | A single, less aggressive tumor that can be removed with a margin of healthy tissue. Surgery, sometimes with radiation, offers a good chance of control. |
| Localized, high-grade | A more aggressive tumor, still confined but with a higher risk of return or spread. Treated with wide surgery plus radiation, with chemotherapy considered case by case. |
| Metastatic | Spread to lymph nodes, lungs, or bone. Treated with surgery or radiation for individual sites and with chemotherapy or clinical trials for widespread disease. |
The standard of care
Myoepithelial Carcinoma of Soft Tissue is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Wide surgical removal (the foundation)
Removing the tumor with a rim of normal tissue around it is the main treatment and the best chance for cure, with the goal of clear margins to prevent local return.
Radiation therapy
Radiation is added before or after surgery for high-grade, large, or close-margin tumors to treat microscopic disease and lower the chance of the cancer coming back where it started.
Chemotherapy (selected cases)
Chemotherapy is considered for high-grade or widespread disease and is used more often in children, where these tumors can behave more aggressively; benefit is individualized.
Follow-up and pathology expertise
Because the diagnosis is subtle and behavior varies, expert sarcoma pathology and regular follow-up imaging (including the chest) are important parts of care.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide. For myoepithelial carcinoma of soft tissue, radiation works alongside surgery: given before or after the operation, it treats the microscopic cells that extend beyond the visible tumor and lowers the chance of the cancer returning at the original site, especially for higher-grade or larger tumors. For isolated areas of spread in the lung or bone, focused techniques such as SBRT can control disease without another operation. Modern planning concentrates the dose on the target and spares healthy tissue, and proton therapy can further protect sensitive nearby structures. Radiation is painless during delivery, given over a planned course, and external-beam treatment leaves no radioactivity in the body.
The main ways radiation is delivered for myoepithelial carcinoma of soft tissue:
Pre- or post-operative external-beam radiation
Shaped beams treat the tumor bed and a margin to destroy microscopic cells beyond the visible tumor, reducing local recurrence.
Proton therapy (selected sites)
When the tumor lies near the spine, pelvis, or other sensitive organs, protons focus the dose on the target while sparing nearby tissue.
Stereotactic body radiation (SBRT)
Delivers a few high, focused doses to an isolated spot of lung or bone spread to control it without surgery.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
EWSR1 rearrangements help define the tumor: Molecular studies found that many soft-tissue myoepithelial tumors carry EWSR1 gene rearrangements, aiding diagnosis and separating them from look-alike sarcomas.[1]
American Journal of Surgical Pathology / Genes, Chromosomes & Cancer
Grade predicts behavior: Clinical series show that how abnormal the cells look (grade) is the strongest predictor of recurrence and spread, guiding how aggressively surgery, radiation, and chemotherapy are used.[2]
Modern Pathology / Sarcoma outcome series
Surgery with radiation for local control: Reports support complete surgical removal combined with radiation for high-risk tumors to reduce local recurrence, with chemotherapy reserved mainly for advanced or pediatric cases.[3]
Journal of Surgical Oncology soft-tissue sarcoma reports
Common questions
Is every myoepithelial tumor a cancer? No. These tumors range from benign myoepithelioma to malignant myoepithelial carcinoma. Pathologists distinguish them by how abnormal the cells look. The benign forms are cured by removal, while the carcinoma can recur or spread and needs more comprehensive treatment.
How is it treated? The main treatment is wide surgery to remove the tumor with a margin of healthy tissue. Radiation is added before or after surgery for high-grade, large, or close-margin tumors, and chemotherapy is considered for aggressive or widespread disease, especially in children.
Does it behave differently in children? It can. Childhood soft-tissue myoepithelial carcinomas may act more aggressively than in adults, so they are managed at pediatric sarcoma centers where chemotherapy is used more often as part of a coordinated plan.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- American Journal of Surgical Pathology / Genes, Chromosomes & Cancer (no indexed identifier — see your care team) ↩
- Modern Pathology / Sarcoma outcome series (no indexed identifier — see your care team) ↩
- Journal of Surgical Oncology soft-tissue sarcoma reports (no indexed identifier — see your care team) ↩